Table Info

Table 3.

Short-term outcomes based on type of temporary right ventricular assist device used

Parameters	RVAD with Protek Duo^® cannula N = 8	Open t-RVAD N = 14	P
Number of days under RVAD	15.6 ± 5.8	15.1 ± 14.2	0.91
Use of renal replacement therapy	5 (62.5)	9 (64.3)	0.92
Number of days under renal replacement therapy	32.6 ± 53.8	22.1 ± 24.5	0.61
Number of days under mechanical ventilation	15 ± 9	27 ± 17	0.044
Use of post-LVAD NO	8 (100)	8 (57.1)	0.05
Number of hours under NO	63 ± 44	110 ± 203	0.41
Number of days under vasopressors	40 ± 28	38 ± 26	0.82
Complications
Bleeding	7 (87.5)	12 (85.7)	0.98
Tamponade	6 (75)	10 (71.4)	0.9
Cannulation site bleeding	1 (12.5)	0	0.36
Other major bleeding	1 (12.5)	0	0.36
Thrombocytopenia (< 50 G/L)	5 (62.5)	13 (92.9)	0.12
Number of units of red blood cells	17 ± 8.9	31 ± 20.5	0.046
Number of units of FFP	2.0 ± 1.91	11.5 ± 10.0	0.005
Number of doses of platelets	4 ± 5	5 ± 3.1	0.66
Stroke	1 (12.5)	2 (7.1)	0.9
Causes of death
MOF	1 (12.5)	2 (14.2)	0.9
Sepsis	0	1 (7.1)	0.9
Stroke	1 (12.5)	2 (14.2)	0.9
Uncontrolled bleeding	0	1 (7.1)	0.9
Pump dysfunction	1 (12.5)	0	0.9
Other	0	0
Withholding or withdrawing life-sustaining treatment	3 (37.5)	5 (35.7)	0.90
Discharge alive from ICU	5 (62.5)	8 (57.1)	0.90
ICU length of stay	49 ± 32	45 ± 22	0.73
Discharge alive from hospital	5 (62.5)	8 (57.1)	0.90
Hospital length of stay	57 ± 39	55 ± 28	0.88
One-year survival	5 (62.5)	7 (50)	0.67

RVAD: right ventricular assist device; LVAD: left ventricular assist device; NO: nitric oxide: FFP: fresh frozen plasma: MOF: multi-organ failure: ICU: intensive care unit. Statistically significant differences are bolded and highlighted

Declarations

Author contributions

AP: Writing—original draft. AK: Data curation. NA: Data curation, Formal Analysis. CB: Writing—original draft. BS: Writing—review & editing.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This study was approved by the institutional review board at Penn State Health: Study identification number: STUDY00012511.

Consent to participate

During the institutional review board (IRB) application, the need for consent was waived as there were no unique patient identifiers that would be used in the data of this project.

Consent to publication

Not applicable.

Availability of data and materials

The datasets generated in this study can be found with the corresponding author and the raw data can be available if requested.

Funding

Not applicable.

Copyright

References

Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1–6. [DOI] [PubMed]

Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163–72. [DOI] [PubMed] [PMC]

Patel ND, Weiss ES, Schaffer J, Ullrich SL, Rivard DC, Shah AS, et al. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Ann Thorac Surg. 2008;86:832–40. [DOI] [PubMed]

Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J Heart Lung Transplant. 2015;34:1123–30. [DOI] [PubMed]

Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, et al. Right heart failure and “failure to thrive” after left ventricular assist device: clinical predictors and outcomes. J Heart Lung Transplant. 2011;30:888–95. [DOI] [PubMed]

Santambrogio L, Bianchi T, Fuardo M, Gazzoli F, Veronesi R, Braschi A, et al. Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interact Cardiovasc Thorac Surg. 2006;5:379–82. [DOI] [PubMed]

Riebandt J, Haberl T, Wiedemann D, Moayedifar R, Schloeglhofer T, Mahr S, et al. Extracorporeal membrane oxygenation support for right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac Surg. 2018;53:590–5. [DOI] [PubMed]

Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, et al.; International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32:157–87. [DOI] [PubMed]

Cheung AW, White CW, Davis MK, Freed DH. Short-term mechanical circulatory support for recovery from acute right ventricular failure: clinical outcomes. J Heart Lung Transplant. 2014;33:794–9. [DOI] [PubMed]

10.

Aggarwal V, Einhorn BN, Cohen HA. Current status of percutaneous right ventricular assist devices: First-in-man use of a novel dual lumen cannula. Catheter Cardiovasc Interv. 2016;88:390–6. [DOI] [PubMed]

11.

Bermudez CA, Lagazzi L, Crespo MM. Prolonged Support Using a Percutaneous OxyRVAD in a Patient with End-Stage Lung Disease, Pulmonary Hypertension, and Right Cardiac Failure. ASAIO J. 2016;62:e37–40. [DOI] [PubMed]

12.

Kazui T, Tran PL, Echeverria A, Jerman CF, Iwanski J, Kim SS, et al. Minimally invasive approach for percutaneous CentriMag right ventricular assist device support using a single PROTEKDuo Cannula. J Cardiothorac Surg. 2016;11:123. [DOI] [PubMed] [PMC]

13.

Leidenfrost J, Prasad S, Itoh A, Lawrance CP, Bell JM, Silvestry SC. Right ventricular assist device with membrane oxygenator support for right ventricular failure following implantable left ventricular assist device placement. Eur J Cardiothorac Surg. 2016;49:73–7. [DOI] [PubMed]

14.

Schmack B, Farag M, Kremer J, Grossekettler L, Brcic A, Raake PW, et al. Results of concomitant groin-free percutaneous temporary RVAD support using a centrifugal pump with a double-lumen jugular venous cannula in LVAD patients. J Thorac Dis. 2019;11:S913–20. [DOI] [PubMed] [PMC]

15.

Schmack B, Weymann A, Popov AF, Patil NP, Sabashnikov A, Kremer J, et al. Concurrent Left Ventricular Assist Device (LVAD) Implantation and Percutaneous Temporary RVAD Support via CardiacAssist Protek-Duo TandemHeart to Preempt Right Heart Failure. Med Sci Monit Basic Res. 2016;22:53–7. [DOI] [PubMed] [PMC]